Skip to Main Content

Suman Laal, PhD

Research Professor, Department of Pathology

Keywords
pathogenesis of M.tuberculosis infection in humans
Summary

M. tuberculosis is a versatile organism, capable of adapting to a variety of different environments. We have provided evidence that M. tuberculosis alters the profile of antigenic proteins expressed in vivo during different stages of disease progression. Understanding of the host-pathogen interactions and the immune events that occur during the early stages post-infection is required for obtaining insight into the pathogenesis of M. tuberculosis infection, and for design of rational intervention strategies for TB. The current interests of our laboratory are two fold. First, to understand the M. tuberculosis-host interaction that occurs during the early stages post-infection, we have conducted studies with animal models of TB, and identified several novel proteins of M. tuberculosis that are expressed in vivo by the inhaled bacteria during the first few weeks post-infection. Many of these proteins have characteristics of surface or secreted proteins, and have structural similarities to proteins involved in binding/adhesion/invasion in other bacteria. Studies aimed at defining the role of these proteins in interaction with the host cells, and in eliciting cellular and humoral immune responses are ongoing. These studies will provide insight into the host-pathogen interaction that occurs upon infection. In addition, these proteins could be candidates for devising vaccines, and/or surrogate markers for identifying individuals with active, pre-clinical infection with M. tuberculosis.

Second, based on a systematic analysis of the humoral immune responses of TB patients at different stages of disease progression, we have identified a set of immuno-dominant culture filtrate proteins of M. tuberculosis that are candidates for devising a rapid, point-of-care diagnostic test for TB. Some of these candidate proteins have been cloned and are currently being dissected to identify the immuno-dominant epitopes associated with active disease. We have also provided evidence that anti-mycobacterial antibodies are present in the urine of TB patients. In view of the lack of resources and infrastructure in developing countries, the high prevalence of active and latent TB in these countries, the increasing incidence of HIV-infection, and the high rates of reactivation TB in the co-infected patients, these studies raise the exciting possibility of developing an inexpensive, safe, urine-based immuno-diagnostic test for TB. Efforts to devise such a test are also ongoing.

Is this your profile?
These focus areas and their associated publications are derived from medical subject headings from PubMed.
represents one publication
Loading...
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

Research Professor, Department of Pathology

PhD from All India Institute of Medical Sciences

Sakamuri, Rama Murthy; Singh, Krishna Kumar; Ryndak, Michelle B; Laal, Suman

Journal of infectious diseases. 2019 Oct 23;

Abhishek, Sudhanshu; Ryndak, Michelle Beth; Choudhary, Alpa; Sharma, Sumedha; Gupta, Amod; Gupta, Vishali; Singh, Nirbhai; Laal, Suman; Verma, Indu

Pathogens & disease. 2019 07 01; 77(5):

Ryndak, Michelle B; Laal, Suman

Frontiers in cellular & infection microbiology. 2019 Sep; 9:299

Abhishek, Sudhanshu; Saikia, Uma Nahar; Gupta, Amod; Bansal, Reema; Gupta, Vishali; Singh, Nirbhai; Laal, Suman; Verma, Indu

Frontiers in cellular & infection microbiology. 2018 Oct; 8:330

Sharma, Sumedha; Ryndak, Michelle B; Aggarwal, Ashutosh N; Yadav, Rakesh; Sethi, Sunil; Masih, Shet; Laal, Suman; Verma, Indu

PLoS one. 2017 Nov; 12(3):e0173508

Ryndak, Michelle B; Chandra, Dinesh; Laal, Suman

Journal of medical microbiology. 2016 May; 65(5):362-369

Ryndak, Michelle B; Singh, Krishna K; Peng, Zhengyu; Laal, Suman

Genomics data. 2015 Sep 01; 5:112-114

Ryndak, Michelle B; Singh, Krishna K; Peng, Zhengyu; Laal, Suman

PLoS one. 2015 Mar; 10(4):e0123745